Catalyst event

Regeneron Pharmaceuticals Inc (REGN)

From KEDI Tesla Fixed Tech100 Index (KTSLT100)

Regeneron is scheduled to report its second quarter 2026 financial and operating results on 2026-07-30; a medium impact is estimated as earnings reports typically drive significant volatility, scheduled.

Korean translation

리제네론, 2026-07-30 2026년 2분기 재무 및 운영 실적을 발표할 예정이며, 실적 발표는 통상적으로 상당한 변동성을 초래하므로 중간 정도의 영향이 예상됨.